Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC59H58ClN7O11 |
InChIKeyCJIXMPCTSMEQPG-UHFFFAOYSA-N |
CAS Registry2447066-37-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 Aug 2020 |